ΒιΆΉΤΌΕΔ

Bio Europe Cover

BIO-Europe 2024

ΒιΆΉΤΌΕΔ BioCapital
4–6 November 2024

Stockholm, Sweden | Experience BIO-Europe and connect with delegates spanning the global life science ecosystem to propel dealmaking and innovation

BIO Europe participants from BioCapital

 

 

Participation from ΒιΆΉΤΌΕΔ  BioCapital 

  Operating Partner Paul Little

  Senior Principal Lars Gredsted

Sessions

Lars Gredsted will be part of the panel discussion "β€œMoney Money Money”: Building a robust venture ecosystem for the next generation of innovations"

November 4 - 15.30
Location: Room K1

In an era of unprecedented scientific advancements, the life sciences sector is ripe with opportunities for groundbreaking discoveries. However, translating these discoveries into marketready solutions requires a robust and resilient venture ecosystem. This panel session will bring together corporate and financial venture capitalists to discuss strategies for fortifying the European venture landscape, ensuring it is well-equipped to support the next generation of life science breakthroughs.

Participants: 

Moderator
 
Melanie Senior
Writer & Analyst
Nature, Evaluate, IN VIVO
Panelists
 
Laura Lane
VP Lilly Ventures , European Head
Eli Lilly & Co
 
MΓ₯rten Steen
Managing Partner
HealthCap
 
Nick Williams
Partner
Medicxi
 
Karl Naegler
Partner
Sofinnova Partners
 
Lars Gredsted
Senior Principal
ΒιΆΉΤΌΕΔ BioCapital
 
Subject

Information

Location
Stockholm
Date and time
November 4-6, 2024